Zimmer Biomet Announces Fourth Quarter and Full-Year 2017 Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. MU
5. GOOGL
6. APGE
7. ABBV
8. USO
9. MSFT
10. IBM

Go back to Zimmer Biomet Announces Fourth Quarter and Full-Year 2017 Results

Zimmer Biomet (ZBH) PT Raised to $146 at Leerink Partners

January 31, 2018 7:50 AM EST

Leerink Partners raised its price target on Zimmer Biomet (NYSE: ZBH) to $146.00 (from $142.00) while maintaining a Outperform rating.

Analyst Richard Newitter commented, "Our OP rating is predicated on the view that for longer-term oriented investors we believe ZBH is a turnaround... More

Zimmer Biomet (ZBH) PT Raised to $155 at Needham & Company

January 30, 2018 1:11 PM EST

Needham & Company raised its price target on Zimmer Biomet (NYSE: ZBH) to $155.00 (from $144.00) while maintaining a Strong Buy rating following in-line Q4 results.

Analyst Mike Matson commented, "ZBH's 4Q17 revenue beat and EPS met consensus and 1Q18 guidance was below consensus. Margins... More

Zimmer Biomet Holdings (ZBH) Reports In-Line Q4 EPS; Guides Q1 Modestly Below the Street

January 30, 2018 7:02 AM EST

Zimmer Biomet Holdings (NYSE: ZBH) reported Q4 EPS of $2.10, in-line with the analyst estimate of $2.10. Revenue for the quarter came in at $2.07 billion versus the consensus estimate of $2.03 billion.

GUIDANCE:

Zimmer Biomet Holdings sees Q1 2018 EPS of $1.84-$1.91, versus the... More